Background-Few population-based studies have ascertained both cerebral and coronary events or considered their relative heritability. Differences in heritability of transient ischemic attack and ischemic stroke versus acute coronary syndromes (ACS) may inform risk prediction, genetic studies, and understanding of disease mechanisms. Methods and Results-In a population-based study of all acute vascular events, irrespective of age, we studied family history of myocardial infarction (MI), stroke, and related risk factors in first-degree relatives. To allow for differences in rates of affected first-degree relatives caused by differences in disease incidence, we looked at the extent to which parental history was associated with affected siblings within disease category. Nine hundred six probands (604 men; mean age, 70 years) with ACS and 1015 (484 men; mean age, 73 years) with cerebral events had complete family history data. In ACS probands, parental MI was associated with MI in Ն1 sibling (1 parent with MI: odds ratio, 1.48; 1.04 to 2.10; Pϭ0.03; both parents with MI: odds ratio, 5.97; 3.23 to 11.03; PϽ0.0001). In probands with cerebral events, however, parental stroke was not associated with sibling stroke. The overall frequency of Ն2 siblings with the same condition was also greater in probands with ACS than in those with cerebral events (odds ratio, 5.43; 3.03 to 9.76; PϽ0.00001), despite similar overall incidence of MI and stroke in our study population. One hundred forty-two (15.7%) cases of ACS occurred in families with Ն2 affected first-degree relatives compared with 56 (5.1%) transient ischemic attack/strokes. All results were similar when analyses were confined to probands with MI only versus stroke only, and independent of smoking. Conclusions-Heritability of coronary events was greater than that of cerebral events, such that MI was more likely to cluster in families than was stroke. (Circ Cardiovasc Genet. 2011;4:390-396.)
ardiovascular disease, mainly constituted by coronary and cerebrovascular disease, is a major cause of mortality and morbidity. 1, 2 Numerous epidemiological studies have determined the associations between family history in firstdegree relatives (FDRs) and risk of vascular events [3] [4] [5] [6] [7] [8] [9] [10] ; although atherosclerosis in one vascular territory predicts development of atherosclerosis in other territories, 11 few studies have looked at relative heritability of cerebral versus coronary events stroke. 12 Indeed, when the data have been collected, family history of all vascular events has usually been grouped into a composite risk factor, particularly in risk prediction tools, none of which consider the relative importance of family history of stroke versus myocardial infarction (MI) [13] [14] [15] Molecular genetic studies, to date, have invariably considered MI and stroke separately, although there is some evidence of common genetic associations. 16 -19 Improved understanding of relative heritability of cerebral versus coronary events may inform risk prediction, genetic studies, as well as disease mechanisms.
Clinical Perspective on p 396
The population-based approach to assessment of heritability 20, 21 is less prone to ascertainment bias than the "extended family" approach, which concentrates on families with high incidence of disease. 19, 20 However, very few populationbased studies have ascertained both coronary and cerebral events. Comparison of heritability of different diseases also presents particular methodological difficulties. First, casecontrol designs are prone to biases in selection of control subjects, 19 -20 particularly a greater likelihood of volunteering to participate if a close relative has had the disease of interest, irrespective of the initial method of selection, and it is possible that the extent of such bias might differ between diseases. Second, differences in rates of affected FDRs will be expected simply on the basis of differences in incidence of the diseases being compared. However, both of these methodological difficulties can be circumvented by doing case:case comparisons (ie, dispensing with control subjects) and by looking at a measure of heritability within the separate disease groups that is relatively independent of disease incidence. We therefore determined the extent to which a parental history of the condition in question (ie, stroke or MI) was associated with siblings affected by the same condition in a prospective, population-based study of probands with all acute vascular events (Oxford Vascular Study, OXVASC).
Methods
The methods of the OXVASC have been published previously. 3 Briefly, OXVASC is a population-based study of all incident or recurrent transient ischemic attacks (TIAs), strokes, acute coronary syndrome (ACS), and acute peripheral vascular events in a population of 91 106 people registered with 63 family physicians in Oxfordshire, United Kingdom. These general practices were originally selected to be representative of the urban and rural mix and the deprivation range of Oxfordshire as a whole. The OXVASC population is 94% white, 3% Asian, 2% Chinese, and 1% Afro-Caribbean. Ascertainment combined prospective daily searches for acute events (hot pursuit) and retrospective searches of hospital-care and primarycare administrative and diagnostic coding data (cold pursuit). Multiple search methods ensure near complete ascertainment of all cases. 3 A physician assessed patients as soon as possible after the ischemic event and gathered clinical data, using a structured questionnaire. Details of the presenting event and medical history were recorded from the patient, their relatives, the family practitioner, and hospital records. Detailed data regarding known risk factors and any previous symptomatic vascular disease were also recorded. If the patient died before assessment, we obtained an eyewitness account of the clinical event and reviewed relevant medical records.
Information about any family history of stroke, MI, peripheral arterial disease, or vascular risk factors and about age at onset of disease in affected relatives (deceased or alive) was collated separately for father, mother, brothers, and sisters (collectively termed FDRs in this study) by use of a structured questionnaire. An inclusive definition of family history of MI was used in this study, including both fatal (62.2% of recorded parental MI) and nonfatal events (37.8%). Family history of known primary intracranial hemorrhage or subarachnoid hemorrhage was not included in analysis of family history of stroke. Age of relatives at the time of their death and the cause of death were also noted when available. The assessment of the family history was based on the patient's or relatives' description and, when necessary, from the family practitioner's notes. The medical history of FDRs was not verified by referring to the medical notes of the relatives or by direct examination/interview of each relative. Instead, we relied on the accuracy of the informant's memory or perception of family members, and therefore this is a "detailed family history approach," using the case-only design, 20 which is a valid approach to measuring genegene interaction under the assumption that the frequencies of genes are independent in the population. 22 However, reported family history of MI has 70% sensitivity and Ͼ95% specificity for MI confirmed by medical records. 23, 24 In the OXVASC study, reported family history in an FDR had 83.3% sensitivity and 100% specificity for medical record-confirmed events in the relative. 25 All patients with a diagnosis of ACS or TIA/stroke were enrolled from April 1, 2002, to September 30, 2008 , and were eligible for the present study. So that similar numbers of TIA/stroke and ACS events were compared, ACS events until March 31, 2009 , were eligible for the study. OXVASC was approved by the local ethics committee.
We defined nonfatal and fatal acute coronary events in probands with published criteria, as reported previously, 26 -28 based on the availability of history, ECG findings, cardiac biomarkers, autopsies, or death certificates. We defined ST-elevation myocardial infarction (STEMI) and non-ST-elevation-myocardial infarction (NSTEMI) by using standard criteria 26 -28 stress test, or a relevant ischemic substrate on coronary angiography with or without subsequent percutaneous coronary intervention. 26 -28 Events with a suggestive clinical presentation but without any of these additional features were classified as probable unstable angina if that was the final diagnosis made by the managing clinician.
To limit cases with missing data, only nonfatal acute coronary events were included in this analysis; that is, sudden cardiac deaths were excluded. Events were classified as incident (first-ever lifetime event) or recurrent to allow analysis of the effect of positive family history on the age of onset of first symptomatic event. Events were also classified as first-ever event during the OXVASC study period to prevent double-counting of patients, which would result in weighting of the effect of family history in favor of individuals with more than 1 event during the study period. Premature events were defined as occurring at Ͻ65 years of age in both sexes. Other studies have used this age limit for prematurity of MI, 29 and the percentage of cases occurring at the age of Ͻ55 years was very low, reflecting the transition of ACS to older age groups in recent years. 3 
Statistical Analysis
Previous genetic epidemiology studies have used the case-only design, and so our methodology of family selection based on probands with either TIA/stroke or ACS is valid. 20, 22 In addition to assessing relative heritability, by comparing sibships in terms of number of siblings affected by MI and stroke, respectively, the relative likelihood of MI versus stroke for a given size of sibship can be assessed.
Categorical variables were compared by means of Pearson 2 test. Continuous variables were compared by means of 2-tailed t tests or ANOVA where appropriate. Odds ratios (ORs) were calculated for positive family history of stroke and MI in probands with ACS and TIA/stroke, separately. ORs, confidence intervals, and probability values were calculated using standard methods, 30 after constructing the relevant 2ϫ2 contingency tables. Odds ratios were calculated using the odds of sibling events when there was no parental history as the baseline. The overall probabilities of having a parental history of MI and of stroke were calculated for ACS and stroke probands. Age of siblings is affected by the age of the proband at ACS or stroke; mean age of siblings was calculated using mean age within each sibship. Therefore, in calculations of mean age of siblings, the total number of affected probands (or sibships) was the denominator rather than the total number of affected siblings. The effects of size of sibship and age of proband at time of vascular event on the probability of MI and of stroke in siblings and in parents were investigated. Finally, the influence of the number of FDRs with stroke or MI on the type of vascular event in the proband was studied. A logistic regression was conducted to further assess the association between number of parents with MI or stroke, respectively (0, 1, or 2) (the independent variable), and presence of MI or stroke, respectively, in the sibship (the dependent variable).
TIA/stroke probands and ACS probands were pooled, and associations between stroke and MI in sibships and proband risk factors were analyzed. ORs were calculated for each risk factor by comparing the odds of sibling history of MI or stroke (the "event") in the presence of the risk factor in probands versus the absence of the risk factor (adjusted and not adjusted for age of the proband at stroke or MI, respectively). Therefore, the OR describes the odds of sibling history of MI or stroke in the presence of that particular risk factor in the proband. Probability values are given for unadjusted ORs (P) and also for ORs with adjustment for proband age (P*). MI indicates myocardial infarction. Odds ratios were calculated by comparing the odds of sibling events in the presence of parental vascular events with the odds of sibling events in the absence of parental vascular events.
Results
Of 1433 consecutive ischemic strokes and TIAs ascertained, family history was unavailable in 174 (12%) cases, most often because the patient died before assessment without an informative relative (nϭ81) or because they did not know their family (nϭ42). Cerebral events (nϭ1015) were incident events (female:male, 531:484; stroke:TIA, 638:377). Of 1266 consecutive ACS cases, family history data were unavailable for 244 (19%) cases, again most often because the patient died before assessment without an informative relative (nϭ103) or because they did not know their family (nϭ52). Nine hundred six cases had incident coronary events: 477 NSTEMI, 252 STEMI, and 177 unstable angina (only collected for the first 2 years of the study) (female:male, 302:604).
ACS probands were younger than TIA/stroke probands, and age at MI was less than age at stroke in parents and siblings in both proband populations (Table 1) . However, there was no difference in the mean size of sibship between ACS probands and TIA/stroke probands (3.24 and 3.19 siblings, respectively), even after stratification by parental history of MI or stroke.
Considering families on the basis of probands, there were 906 families of probands with incident ACS, and 1015 families of probands with incident TIA/stroke. One hundred ninety-one (21.1%) of the 906 families with ACS had at least 1 sibling with MI, and 64 (7.1%) had at least 2 siblings with MI. In 277 (30.6%) families, 1 parent had MI, and in 47 (5.2%) families, both parents had MI. Looking at families with TIA/stroke, 82 of 1015 (8.1%) had at least 1 sibling with stroke, and 14 (1.4%) had at least 2 siblings with stroke. In 216 (21.3%) families, 1 parent had stroke, and in 21 (2.1%) families, both parents had stroke. Parental stroke was slightly more common in TIA/stroke probands than in ACS probands (23.3% versus 18.5%, respectively; OR, 1.34; 1.07 to 1.67; Pϭ0.01), and parental MI tended to be more common in ACS than in TIA/stroke probands (35.8% versus 31.6%, respectively; OR, 1.20; 0.98 to 1.45; Pϭ0.06). Four hundred ninety-two (48.5%) of the TIA/stroke probands and 481 (53.1%) of the ACS probands had no parental history of stroke or MI.
Among 906 sibships of probands with ACS (2601 siblings in total), the odds for affected sibships increases with the number of affected parents (1 affected parent: OR, 1.48; 1.04 to 2.10; Pϭ0.03; both parents affected: OR, 5.97; 3.23 to 11.03; PϽ0.0001) ( Table 2) . Results were qualitatively similar across all ACS subtypes. In a logistic regression model of ACS probands, after age and sex adjustment, the OR for MI in Ն1 sibling increased by 1 (Table 3) , and no trends were apparent in the different etiologic subtypes (TOAST classification), in relation to premature events either in parents or probands, or in relation to sex of proband.
When ACS probands and TIA/stroke probands are pooled, Table 4 illustrates that history of smoking in the proband is associated with sibling history of MI, even after age adjustment (52.3% in probands with sibling history of MI versus 42.9% in probands without sibling history of MI, Pϭ0.006). However, the association between parental history of MI and sibling history of MI was independent of smoking history in the proband (eg, when both parents had MI: OR (sibling MI), 2.79; 1.20 to 6.51; Pϭ0.01 in never-smokers and OR, 4.67; 2.36 to 9.24; PϽ0.0001 in current or past smokers).
Sibling MI was more common than sibling stroke, and there was greater familial clustering of MI than stroke. TIA/stroke probands were more likely to have no siblings affected by stroke than ACS probands were to have no siblings affected by MI (OR, 3.04; 2.31 to 4.01; PϽ0.0001). ACS probands were twice as likely to have 1 sibling with MI as TIA/stroke probands were to have 1 sibling with stroke (OR, 2.27; 1.67 to 3.09; PϽ0.00001 for 1 sibling). However, ACS probands were 5 times more likely than stroke/TIA probands to have Ն2 affected siblings with the same event (OR, 5.43; 3.03 to 9.76; PϽ0.00001). Table 5 compares the number of sibships with parental and sibling stroke versus the number of sibships with parental and sibling MI.
Discussion
Our study has 2 main findings. First, we found greater clustering of MI within families than we did for stroke. This observation remained when we considered the number of affected siblings only, even though the expected sibling incidence of MI and stroke were comparable given the similar incidence in our study population. 3 Second, our measure of the relative heritability of TIA/stroke versus ACS (ie, the extent to which a parental history of the condition in question predicted whether a proband had siblings affected by the same condition) showed much higher heritability for MI than for stroke. Although heritability of stroke and MI have not previously been compared in the same population at the same time, our findings are consistent with previous studies of heritability of the separate conditions, with ischemic stroke usually being found to have relatively low heritability 31, 32 and MI tending to show moderate heritability. 12, 33 Our study had a number of strengths. First, the prospective, population-based approach and the near-complete ascertainment of TIA/stroke and ACS patients make this the most complete family history study to date. Second, the case-case comparison of TIA/stroke probands and ACS probands avoids the biases inherent in selection of control subjects in case-control studies. 20 Third, because the recent rates of incidence of cerebral and coronary disease in our population are relatively similar, 3 use of disease rates in siblings as a measure of relative heritability is appropriate and should not be prone to major bias. Fourth, our findings were independent of age, sex, subtype of vascular event in the proband, and history of smoking.
However, although we consider that our findings are robust, our study does have some limitations. First, only incident cases of ACS and TIA/stroke were included in our analyses, and therefore the findings cannot be extrapolated to ORs were calculated for each risk factor by comparing the odds of sibling history of MI or stroke (the "event") in the presence of the risk factor in probands versus the absence of the risk factor (adjusted and not adjusted for age of the proband at stroke or myocardial infarction, respectively). P values are given for unadjusted ORs (P) and also for ORs with adjustment for proband age (P*). Age-adjusted ORs are shown (OR*).
risk of recurrent events. Second, although several other methods exist to measure heritability and the populationattributable risk of family history, 34 -36 we cannot formally estimate absolute heritability because the OXVASC study did not select patients on the basis of family history of vascular disease. Third, our study may not be powered to consider differences in stroke etiology in either the proband or in parents. Finally, our study was not powered to determine the relative heritability of premature disease.
Our findings may be explained by the fact that the underlying pathophysiology in MI tends to be atherosclerosis and plaque instability, whereas stroke may have greater association with thromboembolism and small-vessel disease. Coronary disease may be a better indicator of generalized atherosclerosis than stroke, and therefore family history of MI may represent a greater risk factor for MI and stroke, whereas family history of stroke is not a strong risk factor for MI. Our results have implications for clinical practice and for future research. In particular, the use of composite measures of family history of vascular disease in risk scores and in screening may not be optimal since the heritability of stroke is much less than that of MI. Further studies are required to determine to what extent family history of MI predicts recurrent events in the secondary prevention setting. The finding of substantially greater heritability of ACS versus TIA/stroke has implications for the likely utility of genome-wide scanning in identifying causative gene loci for stroke. Given the relatively small number of major loci discovered in relation to MI to date, future genome-wide association scans should not be advocated in TIA/stroke and are unlikely to yield more loci for ACS.
In conclusion, heritability of coronary events was greater than that of cerebral ischemic events, such that MI was more likely to cluster in families than was stroke, despite similar overall incidence rates in our study population.
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CLINICAL PERSPECTIVE
Although differences in heritability of cerebrovascular and coronary artery disease may improve risk prediction, future genetic studies, and understanding of disease mechanisms, the relative heritability of acute cerebral and coronary events has rarely been studied, In a prospective, population-based study, the family history of myocardial infarction (MI) and stroke in first-degree relatives was compared between patients presenting with acute coronary syndromes and patients presenting with transient ischemic attacks and stroke. Nine hundred six patients with acute coronary syndromes and 1015 with transient ischemic attacks and stroke were compared. Although parental MI and stroke were common in both patient populations, there was greater clustering of MI than of stroke within families. Patients with acute coronary syndromes were 5 times more likely than patients with strokes or transient ischemic attacks to have 2 or more siblings with disease in the same arterial territory, despite similar overall incidence of MI and stroke in our study population. Moreover, the relative heritability of MI was greater than stroke because parental MI predicted sibling MI, whereas parental stroke did not predict sibling stroke. The use of composite measures of family history of vascular disease in risk scores and in screening may not be optimal because the heritability of stroke is much less than that of MI. Genome-wide scanning is unlikely to identify causative gene loci for stroke, given the finding of substantially greater heritability of MI versus stroke and the relatively small number of major loci discovered in relation to MI to date.
